$MRNA

$198.85 -$1.25 (0.62%) Close

$MRNA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$MRNA Management Team

Dr. Rose Loughlin

Executive Vice President - Research

Age 41

Compensation -

Sex Female

Dr. Jacqueline Miller

Chief Medical Officer

Age 53

Compensation -

Sex Female

Dr. Noubar Afeyan

Non-Executive Independent Chairman of the Board

Co-Founder

Age 62

Compensation $644.4K USD

Sex Male

Dr. Stephen Hoge

President

Age 49

Compensation $9.181M USD

Sex Male

Mr. Stephane Bancel

Chief Executive Officer

Director

Age 52

Compensation $19.88M USD

Sex Male

Mr. James Mock

Chief Financial Officer

Age 48

Compensation $17.21M USD

Sex Male

Mr. Jerh Collins

Chief Technical Operations and Quality Officer

Age 59

Compensation -

Sex Male

Ms. Tracey Franklin

Chief People and Digital Technology Officer

Age 45

Compensation -

Sex Female

Ms. Kate Cronin

Chief Brand Officer

Age 58

Compensation -

Sex Female

Ms. Shannon Klinger

Corporate Secretary

Chief Legal Officer

Age 53

Compensation $17.37M USD

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Rose Loughlin Executive Vice President - Research	41	-	Female
Dr. Jacqueline Miller Chief Medical Officer	53	-	Female
Dr. Noubar Afeyan Non-Executive Independent Chairman of the Board Co-Founder	62	$644.4K USD	Male
Dr. Stephen Hoge President	49	$9.181M USD	Male
Mr. Stephane Bancel Chief Executive Officer Director	52	$19.88M USD	Male
Mr. James Mock Chief Financial Officer	48	$17.21M USD	Male
Mr. Jerh Collins Chief Technical Operations and Quality Officer	59	-	Male
Ms. Tracey Franklin Chief People and Digital Technology Officer	45	-	Female
Ms. Kate Cronin Chief Brand Officer	58	-	Female
Ms. Shannon Klinger Corporate Secretary Chief Legal Officer	53	$17.37M USD	Female

Board of Directors

From the proxy statement filed Mar 16, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

8.1 years

from year joined

CEO also chairs the board

Noubar Afeyan

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Sandra Horning	77	2020 6 years	Independent	Product and Technology · Chair Nominating and Corporate Governance	Revolution Medicines, Inc.	$563,290
Abbas Hussain	61	2024 2 years	Independent	Audit Product and Technology	None stated	$543,290
Noubar Afeyan Board chair	63	2010 16 years	Independent	None stated	Generate Biomedicines, Inc.	Not stated
Stéphane Bancel CEO	53	2011 15 years	Not independent	None stated	Generate Biomedicines, Inc.	Paid as CEO
Elizabeth Nabel	74	2015 11 years	Independent	Compensation and Talent Product and Technology	Medtronic plc	$543,290
François Nader	69	2019 7 years	Independent	Compensation and Talent · Chair Nominating and Corporate Governance · Chair	Tectonic Therapeutic, Inc.	$583,267
David Rubenstein	76	2024 2 years	Independent	Audit	The Carlyle Group	$543,272
Elizabeth Tallett	76	2020 6 years	Independent	Audit · Chair Compensation and Talent	Qiagen, Inc.	$563,277
Sagan	Not stated	Not stated	Independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 16, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$MRNA Management Team

Dr. Rose Loughlin

Dr. Jacqueline Miller

Dr. Noubar Afeyan

Dr. Stephen Hoge

Mr. Stephane Bancel

Mr. James Mock

Mr. Jerh Collins

Ms. Tracey Franklin

Ms. Kate Cronin

Ms. Shannon Klinger

Board of Directors

Related-party transactions

No related-party transactions disclosed